1 Min Read
Nov 23 (Reuters) - Aft Pharmaceuticals Ltd
* HY revenue NZ$36.6 million, up 23 pct
* HY net loss attributable to security holders NZ$6.9 million, down 33% Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.